Samuel C. is a biotech scientist and senior leader with expertise in technology development for genetic vaccines and gene and cell therapies. Currently serving as the Director of R&D at Cytiva, Samuel focuses on advancing nucleic acid drug delivery, lipid nanoparticles, and RNA technologies. Previously, they held the position of Director of Research & Development at Precision NanoSystems Inc., where they contributed to innovative nanoparticle solutions for targeted therapeutic delivery. Samuel completed a Ph.D. at McGill University and holds a bachelor's degree from the University of Victoria.
This person is not in the org chart
This person is not in any teams
This person is not in any offices